UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 984

Sortiert nach

Improved patient survival in hepatitis C virus‐related hepatocellular carcinoma: Do direct‐acting antivirals play a role?

Journal of gastroenterology and hepatology, 2021-12, Vol.36 (12), p.3557-3557

2021

Volltextzugriff (PDF)

Is computed tomography‐enhanced clinical significant portal hypertension surrogate an authentic prognostic predictor for surgical hepatocellular carcinoma?

Journal of gastroenterology and hepatology, 2020-12, Vol.35 (12), p.2289-2289

2020

Volltextzugriff (PDF)

Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy

Clinical radiology, 2012-05, Vol.67 (5), p.429-436

2012

Volltextzugriff (PDF)

A prognostic model for patients with hepatocellular carcinoma within the Milan criteria undergoing non-transplant therapies, based on 1106 patients

Alimentary pharmacology & therapeutics, 2012-09, Vol.36 (6), p.551-559

2012

Volltextzugriff (PDF)

Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma

European journal of surgical oncology, 2007-03, Vol.33 (2), p.208-212

2007

Volltextzugriff (PDF)

Commentary: predicting survival in hepatocellular carcinoma patients - authors' reply

Alimentary pharmacology & therapeutics, 2012-10, Vol.36 (7), p.681-681

2012

Volltextzugriff (PDF)

Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter

Alimentary pharmacology & therapeutics, 2006-01, Vol.23 (1), p.129-135

2006

Volltextzugriff (PDF)

Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis

Digestive and liver disease, 2010-02, Vol.42 (2), p.137-142

2010

Volltextzugriff (PDF)

The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: A prospective survey

Digestive and liver disease, 2008-11, Vol.40 (11), p.882-889

2008

Volltextzugriff (PDF)

Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long‐term outcome

Alimentary pharmacology & therapeutics, 2004-05, Vol.19 (9), p.999-1007

2004

Volltextzugriff (PDF)

Comparison of Percutaneous Acetic Acid Injection and Percutaneous Ethanol Injection for Hepatocellular Carcinoma in Cirrhotic Patients: A Prospective Study

Scandinavian journal of gastroenterology, 2003-07, Vol.38 (7), p.770-778

2003

Volltextzugriff (PDF)

Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study

Annals of oncology, 2003-11, Vol.14 (11), p.1648-1653

2003

Volltextzugriff (PDF)

The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage

Alimentary pharmacology & therapeutics, 2005-03, Vol.21 (6), p.687-694

2005

Volltextzugriff (PDF)

Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients

Journal of viral hepatitis, 2006-05, Vol.13 (5), p.336-342

2006

Volltextzugriff (PDF)

Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study

Annals of oncology, 2004-05, Vol.15 (5), p.775-780

2004

Volltextzugriff (PDF)

Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in Taiwan

Journal of viral hepatitis, 2003-07, Vol.10 (4), p.277-284

2003

Volltextzugriff (PDF)

Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis

Oncogene, 2001-06, Vol.20 (28), p.3620-3628

2001

Volltextzugriff (PDF)

The long-term outcomes of patients with the Barcelona Clinic Liver Cancer stage 0 hepatocellular carcinoma after radiofrequency ablation therapy

Journal of hepatology, 2017, Vol.66 (1), p.S619-S619

2017

Volltextzugriff (PDF)

The impact of esophageal varices on the prognosis of patients with hepatocellular carcinoma after surgical resection: a propensity score matching analysis

Journal of hepatology, 2017, Vol.66 (1), p.S138-S139

2017

Volltextzugriff (PDF)

Validation of novel eligibility criteria by integrating ALBI grade and progression pattern for sorafenib-failed hepatocellular carcinoma

Journal of hepatology, 2017, Vol.66 (1), p.S619-S619

2017

Volltextzugriff (PDF)

The prognosis of single large hepatocellular carcinoma was distinct from the BCLC stage A or B

Journal of hepatology, 2017, Vol.66 (1), p.S618-S619

2017

Volltextzugriff (PDF)

Not all of the patients with hepatitis B-related hepatocellular carcinoma require endoscopic screening for esophageal varices: a large cohort study

Journal of hepatology, 2017, Vol.66 (1), p.S139-S140

2017

Volltextzugriff (PDF)

Do baseline ALT levels predict complications of chronic hepatitis B?

Gut, 2006-05, Vol.55 (5), p.745-745; author reply 746

2006

Volltextzugriff (PDF)

Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D

The Lancet (British edition), 1995-10, Vol.346 (8980), p.939-941

1995

Volltextzugriff (PDF)

Proposal and Validation of a New Model to Estimate Survival for Hepatocellular Carcinoma Patients

Journal of hepatology, 2016, Vol.64 (2), p.S193-S194

2016

Volltextzugriff (PDF)

1 – 25 von 984

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(476)
Mit Volltextzugriff
(939)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(364)
Life Sciences & Biomedicine
(188)
Technology
(185)
Computer Science
(153)
Humans
(133)
Computer Science, Artificial Intelligence
(131)
Engineering
(92)
Male
(85)
Female
(83)
Artificial Intelligence
(81)
Middle Aged
(76)
Signal Processing
(76)
Exact Sciences And Technology
(75)
Applied Sciences
(73)
Telecommunications And Information Theory
(73)
Computer Science; Control Theory; Systems
(72)
Information, Signal And Communications Theory
(72)
Speech And Sound Recognition And Synthesis. Linguistics
(72)
Speech Processing
(72)
Aged
(65)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Improved patient survival in hepatitis C virus‐related hepatocellular carcinoma: Do direct‐acting antivirals play a role?

Is computed tomography‐enhanced clinical significant portal hypertension surrogate an authentic prognostic predictor for surgical hepatocellular carcinoma?

Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy

A prognostic model for patients with hepatocellular carcinoma within the Milan criteria undergoing non-transplant therapies, based on 1106 patients

Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma

Commentary: predicting survival in hepatocellular carcinoma patients - authors' reply

Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter

Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis

The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: A prospective survey

Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long‐term outcome

Comparison of Percutaneous Acetic Acid Injection and Percutaneous Ethanol Injection for Hepatocellular Carcinoma in Cirrhotic Patients: A Prospective Study

Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study

The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage

Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients

Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study

Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in Taiwan

Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis

The long-term outcomes of patients with the Barcelona Clinic Liver Cancer stage 0 hepatocellular carcinoma after radiofrequency ablation therapy

The impact of esophageal varices on the prognosis of patients with hepatocellular carcinoma after surgical resection: a propensity score matching analysis

Validation of novel eligibility criteria by integrating ALBI grade and progression pattern for sorafenib-failed hepatocellular carcinoma

The prognosis of single large hepatocellular carcinoma was distinct from the BCLC stage A or B

Not all of the patients with hepatitis B-related hepatocellular carcinoma require endoscopic screening for esophageal varices: a large cohort study

Do baseline ALT levels predict complications of chronic hepatitis B?

Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D

Proposal and Validation of a New Model to Estimate Survival for Hepatocellular Carcinoma Patients

Suchergebnisse filtern